Nothing Special   »   [go: up one dir, main page]

BREWSTER et al. - Google Patents

The Potential Use ol Gyclodextrins in Parenteral Formulations

BREWSTER et al.

View PDF
Document ID
9238175126998458241
Author
BREWSTER M
SIMPKNSti W
STERN C

External Links

Snippet

The general use of cyclodextrins in drugformulations is reuiewed. The ability of cyclodextrins to form reuersible inclusion complexes with many drugs can eliminate uarious undesirable physicochemical properties. While B-cyclodextrin is extremely useful in many of these …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48961Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
    • A61K47/48969Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene inclusion being performed with a cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30Macromolecular compounds
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetic or similar toilet preparations
    • A61K8/18Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides

Similar Documents

Publication Publication Date Title
JP4439596B2 (en) Pharmaceutical composition containing polar drug or polar prodrug having long shelf life, and method for producing the same
DE69331900T2 (en) CYCLODEXTRIN DERIVATIVES WITH INCREASED WATER SOLUBILITY AND THEIR USE
US5134127A (en) Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
Albers et al. Cyclodextrin derivatives in pharmaceutics
US4727064A (en) Pharmaceutical preparations containing cyclodextrin derivatives
Miranda et al. Cyclodextrins and ternary complexes: technology to improve solubility of poorly soluble drugs
Stella et al. Cyclodextrins: their future in drug formulation and delivery
EP0437478B1 (en) Cyclodextrin-peptide complexes
DE69433052T2 (en) Pharmaceutical compositions containing diclofenac and 2-hydroxypropyl-beta-cyclodextrin
DE69221252T2 (en) Lipophilic compositions of oligosaccharide antibiotic salts
WO1994002518A9 (en) Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US6077871A (en) Droloxifene pharmaceutical compositions
WO1996032135A1 (en) Pharmaceutical composition
EP0399716B1 (en) Hypoallergenic steroidal anesthetic/hypnotic compositions
Rajewski Development and evaluation of the usefulness and parenteral safety of modified cyclodextrins
BREWSTER et al. The Potential Use ol Gyclodextrins in Parenteral Formulations
Devi et al. Cyclodextrins in pharmacy-an overview
WO1996041646A2 (en) Pharmaceutical compositions containing lornoxicam and cyclodextrin
Frijlink Biopharmaceutical aspects of cyclodextrins
JP2805539B2 (en) Poly-γ-cyclodextrin inclusion compound
Panda et al. Cyclodextrin as carrier for drug delivery systems
KUM et al. THE CYCLODEXTRINS: A REVIEW
Puranajoti Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes
CH₂OH et al. BIOMEDICAL USES OF AMORPHOUS WATER-SOLUBLE DERIVATIVES OF CYCLODEXTRINS
CN115969729A (en) Clathrate compound of acetyl dipeptide-1 cetyl ester and preparation method thereof